Genprex
GNPX
Genprex (GNPX) earnings history
Most recent quarter
- Fiscal period
- Q2 2024
- Period end
- Jun 30, 2024
- EPS actual
- −$3,300.00
- EPS estimate
- −$3,300.00
- EPS surprise
- +0.00%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 9, 2024
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2024 | Aug 9, 2024 | −$3,300.00 | −$3,300.00 | +0.00% | $0.00 | SEC |
| Q1 2024 | May 15, 2024 | −$4,059.00 | −$4,059.00 | +0.00% | $0.00 | SEC |
| Q4 2023 | Apr 1, 2024 | −$6,044.50 | −$4,389.00 | +27.39% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$4,400.00 | −$5,060.00 | −15.00% | $0.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$5,720.00 | −$5,720.00 | +0.00% | $0.00 | — |
| Q2 2022 | Aug 12, 2022 | −$4,840.00 | −$4,840.00 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Genprex (GNPX) last report earnings?
Genprex last reported on Aug 9, 2024, covering fiscal Q2 2024.
Did GNPX beat earnings estimates?
Genprex reported EPS of −$3,300.00 for Q2 2024, in line with the −$3,300.00 consensus estimate.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.